FDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development

Details werden geladen...

FDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development | FDA

The U.S. Food and Drug Administration today issued a draft guidance for sponsors seeking approval of human gene therapy products involving genome editing technologies.

FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program | FDA

FDA approves first gene therapy for inherited deafness, shown to restore hearing for children with rare condition - KVIA

Tessera Therapeutics Receives U.S. FDA Fast Track and Orphan Drug Designations for its Lead In Vivo Gene Editing Program TSRA-196 for the Treatment of Adults with AATD | The Manila Times

Login

FDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development | FDA

FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program | FDA

FDA approves first gene therapy for inherited deafness, shown to restore hearing for children with rare condition - KVIA

Tessera Therapeutics Receives U.S. FDA Fast Track and Orphan Drug Designations for its Lead In Vivo Gene Editing Program TSRA-196 for the Treatment of Adults with AATD | The Manila Times